NR4A1 and hyperlipidemia: Thirty-nine (43.3%) patients had comorbidities, including hypertension, hyperlipidemia, diabetes, coronary heart disease, and chronic lung disease, and 69 (76.7%) patients had hormone receptor (estrogen receptor and progesterone receptor) positive.